{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T10:52:39Z","timestamp":1779101559580,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.neuropharm.2006.06.009","type":"journal-article","created":{"date-parts":[[2006,8,9]],"date-time":"2006-08-09T12:34:14Z","timestamp":1155126854000},"page":"993-1003","source":"Crossref","is-referenced-by-count":14,"title":["A slow-onset, long-duration indanamine monoamine reuptake inhibitor as a potential maintenance pharmacotherapy for psychostimulant abuse: Effects in laboratory rat models relating to addiction"],"prefix":"10.1016","volume":"51","author":[{"given":"Eliot L.","family":"Gardner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinhe","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Paredes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan","family":"Spector","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marino","family":"Lepore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-Ming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Froimowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2006.06.009_bib1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0031-9384(85)90315-4","article-title":"A microcomputer-based method for physiologically interpretable measurement of the rewarding efficacy of brain stimulation","volume":"35","author":"Campbell","year":"1985","journal-title":"Physiology and Behavior"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib2","doi-asserted-by":"crossref","first-page":"PL139","DOI":"10.1016\/S0024-3205(96)80014-2","article-title":"Systemic cocaine challenge after chronic cocaine treatment reveals sensitization of extracellular dopamine levels in nucleus accumbens but direct cocaine perfusion into nucleus accumbens does not: implications for the neural locus of cocaine sensitization","volume":"58","author":"Chen","year":"1996","journal-title":"Life Sciences [Pharmacology Letters]"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1037\/0735-7044.101.2.209","article-title":"Fitting intracranial self-stimulation data with growth models","volume":"101","author":"Coulombe","year":"1987","journal-title":"Behavioral Neuroscience"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/01.hdx.0000074519.43281.fa","article-title":"Cardiovascular manifestations of substance abuse","volume":"5","author":"Frishman","year":"2003","journal-title":"Part 1: Cocaine. Heart Disease"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib5","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1021\/jm000201d","article-title":"Slow-onset, long-duration 3-(3\u2032, 4\u2032-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse","volume":"43","author":"Froimowitz","year":"2000","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib6","series-title":"Addiction: Entries and Exits","first-page":"57","article-title":"The neurobiology and genetics of addiction: implications of the \u201cReward Deficiency Syndrome\u201d for therapeutic strategies in chemical dependency","author":"Gardner","year":"1999"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib7","series-title":"Substance Abuse: A Comprehensive Textbook","first-page":"48","article-title":"Brain reward mechanisms","author":"Gardner","year":"2005"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0165-0270(93)90091-5","article-title":"Overview of chemical sampling techniques","volume":"48","author":"Gardner","year":"1993","journal-title":"Journal of Neuroscience Methods"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/(SICI)1098-2396(199910)34:1<11::AID-SYN2>3.0.CO;2-5","article-title":"Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine","volume":"34","author":"Gerasimov","year":"1999","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib10","series-title":"Substance Abuse: A Comprehensive Textbook","first-page":"218","article-title":"Cocaine and crack: clinical aspects","author":"Gold","year":"2005"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib11","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2165\/00003495-200464140-00004","article-title":"Agents in development for the management of cocaine abuse","volume":"64","author":"Gorelick","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib12","first-page":"1551","article-title":"Serotonergic modulation of the behavioral effects of cocaine in the squirrel monkey","volume":"275","author":"Howell","year":"1995","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib13","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/j.1471-4159.1990.tb01982.x","article-title":"Effects of different semipermeable membranes on in vitro and in vivo performance of microdialysis probes","volume":"54","author":"Hsiao","year":"1990","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib14","series-title":"Experimental Design: Procedures for the Behavioral Sciences","author":"Kirk","year":"1982"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib15","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0022-3565(24)37310-0","article-title":"Discriminative stimulus properties of cocaine: enhancement by monomaine reuptake blockers","volume":"284","author":"Kleven","year":"1998","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib16","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0022-3565(24)37048-X","article-title":"Effects of proposed treatments for cocaine addiction on hemodynamic responsiveness to cocaine in conscious rats","volume":"283","author":"Knuepfer","year":"1997","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib17","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0091-3057(90)90242-A","article-title":"Postcocaine depression and sensitization of brain-stimulation reward: analysis of reinforcement and performance effects","volume":"36","author":"Kokkinidis","year":"1990","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib18","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/0024-3205(86)90501-1","article-title":"Amphetamine withdrawal: a behavioral evaluation","volume":"38","author":"Kokkinidis","year":"1986","journal-title":"Life Sciences"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib19","unstructured":"Lepore, M. 1993. A Behavioral and Neurological Analysis of the Self-Administration of Brain-Stimulation Technique: A Model of Drug Self-Administration. PhD dissertation, McGill University, Montreal, QC."},{"key":"10.1016\/j.neuropharm.2006.06.009_bib20","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0091-3057(92)90362-J","article-title":"Modeling drug kinetics with brain stimulation: dopamine antagonists increase self-stimulation","volume":"41","author":"Lepore","year":"1992","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib21","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4088\/JCP.v59n0605","article-title":"Methylphenidate treatment for cocaine abusers with adult attention-deficit\/hyperactivity disorder: a pilot study","volume":"59","author":"Levin","year":"1998","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib22","first-page":"17","article-title":"Postcocaine anhedonia: an animal model of cocaine withdrawal","volume":"4","author":"Markou","year":"1991","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0893-133X(97)00113-9","article-title":"Neurobiological similarities in depression and drug dependence: a self medication hypothesis","volume":"18","author":"Markou","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0031-9384(86)90388-4","article-title":"The cure-shift paradigm in self-stimulation","volume":"37","author":"Miliaressis","year":"1986","journal-title":"Physiology and Behavior"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.neuropharm.2004.03.020","article-title":"Nucleus accumbens serotonin1A receptors control cocaine-induced hyperactivity but not local serotonin increase: an in vivo microdialysis study","volume":"47","author":"M\u00fcller","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib26","series-title":"Guide for the Care and Use of Laboratory Animals","author":"National Academy of Sciences (National Research Council, Commission on Life Sciences, Institute of Laboratory Animal Resources)","year":"1996"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib27","series-title":"NIDA Research Report \u2013 Cocaine Abuse and Addiction (NIH Publication No. 99\u20134342, revised November 2004)","author":"National Institute on Drug Abuse","year":"2004"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0022-3565(24)35071-2","article-title":"Effects of the long-acting monoamine reuptake inhibitor indatraline on cocaine self-administration in rhesus monkeys","volume":"291","author":"Negus","year":"1999","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pharmthera.2005.06.018","article-title":"Critical assessment of how to study addiction and its treatment: human and non-human animal models","volume":"108","author":"O'Brien","year":"2005","journal-title":"Pharmacology and Therapeutics"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib30","first-page":"13","article-title":"Some relationships between addiction and drug delivery to the brain","volume":"120","author":"Oldendorf","year":"1992","journal-title":"NIDA Research Monograph"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib31","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1982"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib32","first-page":"241","article-title":"Vanoxerine: National Institute on Drug Abuse","volume":"1","author":"Preti","year":"2000","journal-title":"Current Opinion in Investigational Drugs"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib33","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF02245136","article-title":"Stereoselective behavioral effects of Lu 19-005 in monkeys: relation to binding at cocaine recognition sites","volume":"107","author":"Rosenzweig-Lipson","year":"1992","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02740680","article-title":"A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development \u2013 focus on GBR-12909","volume":"11","author":"Rothman","year":"1995","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00213-001-0972-3","article-title":"Effects of GBR 12909, WIN 35,428 and indatraline on cocaine self-administration and cocaine seeking in rats","volume":"160","author":"Schenk","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib36","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1124\/jpet.300.1.180","article-title":"Interactions between cocaine and dopamine agonists on cardiovascular function in squirrel monkeys","volume":"300","author":"Schindler","year":"2002","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib37","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/archpsyc.1995.03950180042006","article-title":"Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain","volume":"52","author":"Volkow","year":"1995","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib38","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/026988119901300406","article-title":"Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans","volume":"13","author":"Volkow","year":"1999","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib39","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1126\/science.1058043","article-title":"Relapse to cocaine-seeking after hippocampal theta burst stimulation","volume":"292","author":"Vorel","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib40","doi-asserted-by":"crossref","first-page":"9595","DOI":"10.1523\/JNEUROSCI.22-21-09595.2002","article-title":"Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats","volume":"22","author":"Vorel","year":"2002","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib41","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0006-8993(92)91327-B","article-title":"Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration","volume":"593","author":"Weiss","year":"1992","journal-title":"Brain Research"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib42","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0959-4388(96)80079-1","article-title":"Neurobiology of addiction","volume":"6","author":"Wise","year":"1996","journal-title":"Current Opinion in Neurobiology"},{"key":"10.1016\/j.neuropharm.2006.06.009_bib43","series-title":"Neurobiology of Mental Illness","first-page":"683","article-title":"Animal models of addiction","author":"Wise","year":"2004"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390806001936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390806001936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T11:14:57Z","timestamp":1736507697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390806001936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0028390806001936"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2006.06.009","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}